Taghi Manshouri
- Genetics top 0.1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 64
- Chronic Lymphocytic Leukemia Research 28
- Hematology top 0.2%
- Chronic Myeloid Leukemia Treatments 48
- Acute Myeloid Leukemia Research 38
- Multiple Myeloma Research and Treatments 14
- Rheumatology top 0.5%
- Eosinophilic Disorders and Syndromes 24
- Immunology top 2%
- Oncology top 2%
-
- Angiogenesis and VEGF in Cancer 15
-
- Lymphoma Diagnosis and Treatment 14
- Co-authors
- Hagop M. KantarjianSrđan VerstovšekMaher AlbitarJörge E. CortesMichael J. KeatingZeev EstrovDeborah A. ThomasFrancis J. Giles
- Cited by
- GeneticsHematologyRheumatology
- Journals
- The Journal of Experimental Medicine (1 paper)Journal of Clinical Oncology (2 papers)Blood (57 papers)
- Partner nations
- United StatesCroatiaSwitzerland
In The Last Decade
Taghi Manshouri
135 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Genetics 3.2k
- Hematology 3.1k
- Rheumatology 1.2k
- Immunology 1.0k
- Oncology 1.3k
Countries citing papers authored by Taghi Manshouri
This map shows the geographic impact of Taghi Manshouri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taghi Manshouri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taghi Manshouri more than expected).
Fields of papers citing papers by Taghi Manshouri
This network shows the impact of papers produced by Taghi Manshouri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taghi Manshouri. The network helps show where Taghi Manshouri may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Taghi Manshouri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2016 | 115 | |
| 7 | 2016 | 29 | |
| 8 | 2013 | 83 | |
| 9 | 2011 | 83 | |
| 10 | 2011 | 80 | |
| 11 | 2010 | 227 | |
| 12 | 2009 | 13 | |
| 13 | 2008 | 66 | |
| 14 | The dual ABL/SRC inhibitors dasatinib, SKI-606, and INNO-406 are potent inhibitors of T cell acute lymphoblastic leukemia cell lines expressing the NUP214-ABL1 fusion kinase | 2007 | 1 |
| 15 | 2006 | 16 | |
| 16 | 2003 | 11 | |
| 17 | 2001 | 11 | |
| 18 | Significance of FHIT expression in chronic myelogenous leukemia. | 1999 | 9 |
| 19 | 1999 | 15 | |
| 20 | 1997 | 27 |
About Taghi Manshouri
Taghi Manshouri is a scholar working on Genetics, Hematology and Rheumatology, having authored 143 papers that have together received 6.2k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (64 papers), Chronic Myeloid Leukemia Treatments (48 papers), Acute Myeloid Leukemia Research (38 papers), Chronic Lymphocytic Leukemia Research (28 papers), Eosinophilic Disorders and Syndromes (24 papers), Angiogenesis and VEGF in Cancer (15 papers), Multiple Myeloma Research and Treatments (14 papers) and Lymphoma Diagnosis and Treatment (14 papers). The work is most often cited by research in Genetics (3.2k citations), Hematology (3.1k citations) and Rheumatology (1.2k citations). Taghi Manshouri has collaborated with scholars based in United States, Croatia and Switzerland. Frequent co-authors include Hagop M. Kantarjian, Srđan Verstovšek, Maher Albitar, Jörge E. Cortes, Michael J. Keating, Zeev Estrov, Deborah A. Thomas, Francis J. Giles, Susan O’Brien and Alfonso Quintás‐Cardama. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.